These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
954 related articles for article (PubMed ID: 28739701)
1. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1 Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer. Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study. Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981 [TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756 [TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer. Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer. Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145 [TBL] [Abstract][Full Text] [Related]
7. High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy. Lim YJ; Koh J; Kim K; Chie EK; Kim B; Lee KB; Jang JY; Kim SW; Oh DY; Bang YJ; Ha SW Radiother Oncol; 2015 Oct; 117(1):165-70. PubMed ID: 26235847 [TBL] [Abstract][Full Text] [Related]
8. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy. Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study. Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075 [TBL] [Abstract][Full Text] [Related]
10. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Wang K; Shen T; Siegal GP; Wei S Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841 [TBL] [Abstract][Full Text] [Related]
12. Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients. El-Guindy DM; Helal DS; Sabry NM; Abo El-Nasr M J Egypt Natl Canc Inst; 2018 Dec; 30(4):125-131. PubMed ID: 30337185 [TBL] [Abstract][Full Text] [Related]
13. Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8 Munari E; Marconi M; Querzoli G; Lunardi G; Bertoglio P; Ciompi F; Tosadori A; Eccher A; Tumino N; Quatrini L; Vacca P; Rossi G; Cavazza A; Martignoni G; Brunelli M; Netto GJ; Moretta L; Zamboni G; Bogina G Front Immunol; 2021; 12():680973. PubMed ID: 34122444 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II-III colorectal cancer. Huang CY; Chiang SF; Ke TW; Chen TW; You YS; Chen WT; Chao KSC Sci Rep; 2018 Oct; 8(1):15658. PubMed ID: 30353144 [TBL] [Abstract][Full Text] [Related]
15. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma. Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor PD-L1 expression combined with CD8 Wang Q; Lou W; Di W; Wu X Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888 [TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer. Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749 [TBL] [Abstract][Full Text] [Related]